MedTrace Logo

Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

NCT03175939 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 263

Last updated 2017-06-05

No results posted yet for this study

Summary

This study evaluates whether some patients with nasopharyngeal carcinoma but with low risk of distant metastasis can be treated with only radiotherapy and concomitant chemotherapy but without additional adjuvant chemotherapy.

Conditions

  • Nasopharyngeal Cancer

Interventions

RADIATION

Radiotherapy

External beam radiotherapy with curative intent, at least 66 Gy

DRUG

Cisplatin

cisplatin IV injection over 3 hours

DRUG

5-FU

5-FU IV 24 hours continuous infusion

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Skye Hung-Chun Cheng, M.D. · Koo Foundation Sun Yat-Sen Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-01
Primary Completion
2008-12-31
Completion
2014-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03175939 on ClinicalTrials.gov